Table 4 Percentage of patients on monotherapy during the complete biologic course, according to biologic treatment course

Number of patients

79

25

9

2

115

% Patients on biologic monotherapy during the complete biologic course (95 % CI)

15 (8–25)

48 (28–69)

44 (14–79)

50 (13–99)

25 (18–34)

% Patients on biologic monotherapy during the complete biologic course due to Medical prescription (95 % CI)

10 (4–19)

40 (21–61)

33 (7–70)

0

18 (12–26)

% Patients biologic monotherapy during the complete biologic course due to patient’s decision (95 % CI)

5 (1–12)

8 (1–26)

11 (0.2–48)

50 (13–99)

7 (3–13)